Ziconotide: a new nonopioid intrathecal analgesic for the treatment of chronic pain.
about
Engineering a stable and selective peptide blocker of the Kv1.3 channel in T lymphocytesThe application of genomic and molecular data in the treatment of chronic cancer pain.Natural products: a continuing source of novel drug leadsAmbroxol: a CNS drug?Safety and efficacy of intrathecal ziconotide in the management of severe chronic pain.The discovery and development of analgesics: new mechanisms, new modalities.Omega-conotoxins as experimental tools and therapeutics in pain management.Conotoxin therapeutics: a pipeline for success?Safety and efficacy of intrathecal drug delivery for pain.Identification and characterization of RNA aptamers: A long aptamer blocks the AMPA receptor and a short aptamer blocks both AMPA and kainate receptors.Neuronal cell lines as model dorsal root ganglion neurons: A transcriptomic comparison.Sustained relief of ongoing experimental neuropathic pain by a CRMP2 peptide aptamer with low abuse potential.δ-Ctenitoxin-Pn1a, a Peptide from Phoneutria nigriventer Spider Venom, Shows Antinociceptive Effect Involving Opioid and Cannabinoid Systems, in RatsHomology-guided mutational analysis reveals the functional requirements for antinociceptive specificity of collapsin response mediator protein 2-derived peptides.An evaluation of the antinociceptive effects of Phα1β, a neurotoxin from the spider Phoneutria nigriventer, and ω-conotoxin MVIIA, a cone snail Conus magus toxin, in rat model of inflammatory and neuropathic pain.A definition of refractory pain to help determine suitability for device implantation.In vitro stability of low-concentration ziconotide alone or in admixtures in intrathecal pumps.
P2860
Q24657847-1782B7AA-6F1A-49ED-A423-626615E65C9EQ34207230-54F61FF0-FC38-48C2-9FC0-FCFF34D6A48AQ34328933-FD92F380-FF42-4E12-A448-834BB4B713B5Q37164691-4590B234-ACC8-498D-87BB-1DCBF908830EQ37261060-2F52C566-601B-431A-AD7B-650EFF3E1255Q37805995-12B5C9C4-9941-496E-8991-A3FD2E3543A1Q38087443-21724930-88BA-4270-BEF2-84425BCA16F5Q38088765-BFB922D2-E14F-4CFC-A260-C7B72582018AQ38198087-5D73DB80-7735-48D8-92B8-3FAC0CF5753FQ38288608-28DB6912-7EE4-4709-93F6-E426F6C05FB7Q38447984-EA1BBAA3-A60C-4A4B-BCE9-5F780FD45B7AQ39168504-3CB4C9BD-2AB9-411D-B633-751BC32EC8E6Q39851420-D1E17852-5DFF-41C1-8AB4-E346AAF33FF4Q40349390-21BBFA2C-3262-4D57-9F40-41637C45F7F7Q43854864-6C5C3776-6C5C-40DE-B476-CBC1328FF053Q44150205-AD43B00C-7D1F-49C3-BB89-6312AEE89382Q47914210-4D65489D-C0AF-4C3F-B6CB-60F54C75D124
P2860
Ziconotide: a new nonopioid intrathecal analgesic for the treatment of chronic pain.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Ziconotide: a new nonopioid intrathecal analgesic for the treatment of chronic pain.
@ast
Ziconotide: a new nonopioid intrathecal analgesic for the treatment of chronic pain.
@en
type
label
Ziconotide: a new nonopioid intrathecal analgesic for the treatment of chronic pain.
@ast
Ziconotide: a new nonopioid intrathecal analgesic for the treatment of chronic pain.
@en
prefLabel
Ziconotide: a new nonopioid intrathecal analgesic for the treatment of chronic pain.
@ast
Ziconotide: a new nonopioid intrathecal analgesic for the treatment of chronic pain.
@en
P2860
P1476
Ziconotide: a new nonopioid intrathecal analgesic for the treatment of chronic pain.
@en
P2093
Mark S Wallace
P2860
P304
P356
10.1586/14737175.6.10.1423
P577
2006-10-01T00:00:00Z